1.75 mg semaglutide FDA approves obesity drug that helped people cut weight 15% semaglutide free trial The SELECT

Monitoring mental health during the transition to GLP-1 therapy is essential, and any significant mood changes should prompt immediate discussion with a healthcare provider

In addition, the results of the in vitro NRVM assay with oil red O staining also confirmed that PE stimulation can also increase myocardial lipid accumulation (Fig

Potential expanded uses of GLP-1 agonists New research suggests that GLP-1 agonists can help treat conditions beyond their approved uses

Key takeaways: GLP-1 medications are primarily used for weight loss, but are increasingly being explored in relation to PCOS and perimenopause Early evidence (mainly in women with obesity and PCOS) suggests GLP-1s may improve insulin resistance and support more regular menstrual cycles and ovulation There is currently limited research on how GLP-1 medications affect periods, fertility, PMS, or menopause symptoms in the wider population Period tracking apps like Clue may help users monitor cycle and symptom changes while using GLP-1 medications 1

Should the trial figures cited for tirzepatide in this post be trusted

Approximately 39 amino acids similar in length to tirzepatide, longer than semaglutide (31 amino acids)